Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Sudden Cardiac Death
100%
Sudden Cardiac Death Prevention
100%
Heart Failure Medication
100%
Device Therapy
75%
Improved Outcomes
25%
Clinical Trials
25%
Primary Prevention
25%
Beneficial Effects
25%
New Drugs
25%
Pathophysiological Mechanisms
25%
Beta-blockers
25%
Left Ventricular Ejection Fraction
25%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
25%
Implantable Defibrillator
25%
Ventricular Arrhythmia
25%
Cardioverter-defibrillator Implantation
25%
Heart Failure Patients
25%
Reduced Ejection Fraction
25%
Arrhythmia
25%
Biventricular Pacing
25%
Angiotensin Receptor Blockers
25%
Cardiac Fibrosis
25%
Mineralocorticoid Receptor Antagonists
25%
Soluble Guanylate Cyclase Stimulator
25%
Structural Heart Disease
25%
Angiotensin Receptor-neprilysin Inhibitor
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
New Drugs Agents
25%
Medicine and Dentistry
Drug Therapy
100%
Heart Failure
100%
Sudden Cardiac Death
100%
Heart Failure with Reduced Ejection Fraction
66%
Device Therapy
50%
Primary Prevention
33%
Implantable Automatic Defibrillator
33%
Decision Making
16%
Clinical Trial
16%
Heart Disease
16%
ACE Inhibitor
16%
Cardiac Dysrhythmia
16%
Ejection Fraction
16%
Heart Left Ventricle Ejection Fraction
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Heart Ventricle Arrhythmia
16%
Cardiac Resynchronization Therapy
16%
Cardiac Fibrosis
16%
Beta Adrenergic Receptor Blocking Agent
16%
Mineralocorticoid Antagonist
16%
Guanylate Cyclase Activator
16%
Enkephalinase Inhibitor
16%
Angiotensin Receptor Antagonist
16%
Angiotensin Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Sudden Cardiac Death
100%
Heart Failure with Reduced Ejection Fraction
66%
Clinical Trial
16%
Heart Disease
16%
Heart Arrhythmia
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Heart Ventricle Arrhythmia
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Beta Adrenergic Receptor Blocking Agent
16%
Heart Muscle Fibrosis
16%
Angiotensin Receptor Antagonist
16%
Mineralocorticoid Antagonist
16%
Guanylate Cyclase Activator
16%
Enkephalinase Inhibitor
16%
Angiotensin Receptor
16%